273
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Real-World Prescribing Patterns for Hypertensive Children in China from 2018 to 2021: A Cross-Sectional Multicenter Study

, , ORCID Icon, , , , ORCID Icon & show all
Pages 287-299 | Received 11 Oct 2022, Accepted 18 Feb 2023, Published online: 27 Feb 2023

References

  • Xie K, Gao X, Bao L, Shan Y, Shi H, Li Y; UPPDATE Investigators. The integrated management of hypertension in general hospitals and community hospitals. Risk Manag Healthc Policy. 2021;14:2537–2545. doi:10.2147/RMHP.S306735
  • Jiang Q, Gong D, Li H, et al. Development and validation of a risk score screening tool to identify people at risk for hypertension in Shanghai, China. Risk Manag Healthc Policy. 2022;15:553–562. doi:10.2147/RMHP.S354057
  • Xu L, Wen X, Yang Y, Cui D. Trends and comparisons of blood pressure and fasting plasma glucose in patients with hypertension, diabetes, and comorbidity: 4-year follow-up data. Risk Manag Healthc Policy. 2022;15:2221–2232. doi:10.2147/RMHP.S385815
  • Lin H, Wu Y, Wu J, Chen Q, Yu J, Lin Y. Prevalence of hypertension and 10-Year cardiovascular disease risk among older adults living in Quanzhou, a coastal region of southeast China. Risk Manag Healthc Policy. 2022;15:1045–1053. doi:10.2147/RMHP.S341148
  • Cohn J, Bygrave H, Roberts T, Khan T, Ojji D, Ordunez P. Addressing failures in achieving hypertension control in low- and middle-income settings through simplified treatment algorithms. Glob Heart. 2022;17(1):28. doi:10.5334/gh.1082
  • Li SS, Li JM, Liu LL, Liu W, Yang H, Feng CG. Analysis of the risk factors related to the success rate of distal transradial artery access in patients with coronary heart disease. Risk Manag Healthc Policy. 2022;15:657–663. doi:10.2147/RMHP.S357780
  • Nie Z, Xu H, Chen C, et al. Population attributable risks of potential modifiable factors for atrial fibrillation in China: a national survey. Risk Manag Healthc Policy. 2022;15:1215–1224. doi:10.2147/RMHP.S360285
  • Afaa TJ, Seneadza H, Ameyaw E, Rodrigues OP. Blood pressure profile, prevalence of hypertension and associated familial factors in school children in Accra, Ghana. Niger J Clin Pract. 2022;25(4):386–390. doi:10.4103/njcp.njcp_1832_21
  • Dong Y, Ma J, Song Y, et al. Secular trends in blood pressure and overweight and obesity in Chinese boys and girls aged 7 to 17 years from 1995 to 2014. Hypertension. 2018;72(2):298–305. doi:10.1161/HYPERTENSIONAHA.118.11291
  • Joint Committee for Guideline Revision. 2018 Chinese guidelines for prevention and treatment of hypertension-A report of the revision committee of Chinese guidelines for prevention and treatment of hypertension. J Geriatr Cardiol. 2019;16(3):182–241. doi:10.11909/j.issn.1671-5411.2019.03.014
  • Fox C. Pediatric hypertension. Prim Care. 2021;48(3):367–378. doi:10.1016/j.pop.2021.04.001
  • Cormick G, Ciapponi A, Cafferata ML, Cormick MS, Belizán JM. Calcium supplementation for prevention of primary hypertension. Cochrane Database Syst Rev. 2022;1(1):CD010037. doi:10.1002/14651858.CD010037.pub4
  • Yang R, Tang J, Zhuo Y, Kuang M, Liu H. Current prescription status of antihypertensive drugs in Chinese patients with hypertension: analysis by type of comorbidities. Clin Exp Hypertens. 2022;44(3):240–248. doi:10.1080/10641963.2021.2022688
  • Li LC, Chen J, Zhu XB, et al. Trends of complications in patients with Parkinson’s disease in seven major cities of China from 2016 to 2019. Int Clin Psychopharmacol. 2021;36(5):274–278. doi:10.1097/YIC.0000000000000370
  • Ying J, Li LC, Wu CY, Yu ZW, Kan LD. The status of proton pump inhibitor use: a prescription survey of 45 hospitals in China. Rev Esp Enferm Dig. 2019;111(10):738–743. doi:10.17235/reed.2019.6155/2019
  • Gong X, He Q, Yan J, et al. A drug utilization study of oral anticoagulants in five representative cities of China between 2015 and 2019. J Clin Pharm Ther. 2022;47(1):38–45. doi:10.1111/jcpt.13538
  • Flynn JT, Kaelber DC, Baker-Smith CM, Subcommittee on Screening and Management of High Blood Pressure in Children. Clinical practice guideline for screening and management of high blood pressure in children and adolescents. Pediatrics. 2017;140(3):e20171904. doi:10.1542/peds.2017-1904
  • Awazu M. Isolated nocturnal hypertension in children. Front Pediatr. 2022;10:823414. doi:10.3389/fped.2022.823414
  • Tran AH, Urbina EM. Hypertension in children. Curr Opin Cardiol. 2020;35(4):376–380. doi:10.1097/HCO.0000000000000744
  • Pérez-Gimeno G, Rupérez AI, Vázquez-Cobela R, et al. Energy dense salty food consumption frequency is associated with diastolic hypertension in Spanish children. Nutrients. 2020;12(4):1027. doi:10.3390/nu12041027
  • Song P, Zhang Y, Yu J, et al. Global prevalence of hypertension in children: a systematic review and meta-analysis. JAMA Pediatr. 2019;173(12):1154–1163. doi:10.1001/jamapediatrics.2019.3310
  • Kharbanda EO, Asche SE, Sinaiko AR, et al. Clinical decision support for recognition and management of hypertension: a randomized trial. Pediatrics. 2018;141(2):e20172954. doi:10.1542/peds.2017-2954
  • Rabi DM, McBrien KA, Sapir-Pichhadze R, et al. Hypertension Canada’s 2020 comprehensive guidelines for the prevention, diagnosis, risk assessment, and treatment of hypertension in adults and children. Can J Cardiol. 2020;36(5):596–624. doi:10.1016/j.cjca.2020.02.086
  • Singh Y, Samuel VP, Dahiya S, et al. Combinational effect of angiotensin receptor blocker and folic acid therapy on uric acid and creatinine level in hyperhomocysteinemia-associated hypertension. Biotechnol Appl Biochem. 2019;66(5):715–719. doi:10.1002/bab.1799
  • Robinson CH, Chanchlani R. High blood pressure in children and adolescents: current perspectives and strategies to improve future kidney and cardiovascular health. Kidney Int Rep. 2022;7(5):954–970. doi:10.1016/j.ekir.2022.02.018